Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Current Parent Company Summary

Current Parent Company Name: AstraZeneca
Ownership Structure: publicly traded (ticker symbol LSE: AZN)
Headquartered in: United Kingdom
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $1,539,362,457
Number of records: 32
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$594,000,0004
government-contracting-related offenses$556,241,15913
safety-related offenses$198,008,2132
competition-related offenses$184,522,0007
consumer-protection-related offenses$5,391,0001
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$594,000,0004
False Claims Act and related$556,241,15913
drug or medical equipment safety violation$198,000,0001
price-fixing or anti-competitive practices$158,000,0005
Foreign Corrupt Practices Act$21,000,0001
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

Individual Penalty Records:

Click on the company or penalty amount for more information on each case.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyPrimary Offense TypeYearAgencyPenalty Amount sort icon
AstraZeneca LPoff-label or unapproved promotion of medical products2010FDA$520,000,000
AstraZeneca Pharmaceuticals LPFalse Claims Act and related2003DOJ_CIVIL$354,900,000
AstraZeneca Pharmaceuticals LPoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
AstraZenecadrug or medical equipment safety violation2010private lawsuit-federal$198,000,000
AstraZenecaFalse Claims Act and related2018TX-AG$110,000,000
AstraZeneca Pharmaceuticals LPprice-fixing or anti-competitive practices2011private lawsuit-federal$90,000,000
AstraZeneca Pharmaceuticalsoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
AstraZeneca LPFalse Claims Act and related2015DOJ_CIVIL$46,500,000
AstraZeneca LPFalse Claims Act and related2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000
AstraZeneca Pharmaceuticals LPFalse Claims Act and related2003MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000
AstraZenecaprice-fixing or anti-competitive practices2007private lawsuit-federal$24,000,000
Alexion Pharmaceuticals Inc.Foreign Corrupt Practices Act2020SEC$21,000,000
AstraZeneca Pharmaceuticals LPprice-fixing or anti-competitive practices2012private lawsuit-federal$20,000,000
AstraZenecaFalse Claims Act and related2009KY-AG$14,700,000
Alexion Pharmaceuticals Inc.False Claims Act and related2019DOJ_CIVIL$13,000,000
AstraZeneca Pharmaceuticals LPprice-fixing or anti-competitive practices2011private lawsuit-federal$13,000,000
AstraZeneca Pharmaceuticals LPprice-fixing or anti-competitive practices2013private lawsuit-federal$11,000,000
AstraZeneca LPFalse Claims Act and related2015DOJ_CIVIL$7,900,000
AstraZeneca PLCkickbacks and bribery2016SEC$5,522,000
AstraZenecaoff-label or unapproved promotion of medical products2013KY-AG$5,500,000
AstraZenecaconsumer protection violation2010KY-AG$5,391,000
AstraZeneca Pharmaceuticals, LPFalse Claims Act and related2010HI-AG$3,333,333
AstraZeneca PharmaceuticalsFalse Claims Act and related2009DOJ_CIVIL$2,600,000
AstraZeneca Pharmaceuticals LPFalse Claims Act and related2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000
AstraZeneca Pharmaceuticals LP and AstraZeneca LPFalse Claims Act and related2011ID-AG$2,500,000
AstraZenecaFalse Claims Act and related2004FL-AG$807,826
AstraZenecaemployment discrimination2021OFCCP$560,000
AstraZenecaemployment discrimination2008private lawsuit-state$350,000
AstraZenecaemployment discrimination2011OFCCP$250,000
MEDIMMUNE DISTRIBUTION LLCenvironmental violation2005EPA$21,125
ASTRAZENECA PLPenvironmental violation2021EPA$18,960
ALEXION PHARMACEUTICALS, INC.workplace safety or health violation2012OSHA$8,213
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.